Senti Biosciences, Inc. (SNTI)
(Delayed Data from NSDQ)
$2.24 USD
+0.04 (1.82%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $2.21 -0.03 (-1.34%) 7:10 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Senti Biosciences, Inc. (SNTI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$60.00 | $60.00 | $60.00 | 2,627.27% |
Price Target
Only one analyst offered a short-term price target of $60.00 for Senti Biosciences, Inc. This represents an increase of 2% from the last closing price of $2.20.
Analyst Price Targets (1 )
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for Senti Biosciences, Inc. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 1.00 a month ago based on just one Strong Buy recommendation.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/2/2024 | Chardan Capital Markets | Yevgeniya Livshits | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 1 |
Average Target Price | $60.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 73 of 252 |
Current Quarter EPS Est: | NA |
SNTI FAQs
Senti Biosciences, Inc. (SNTI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 1 brokerage firms.
The average price target for Senti Biosciences, Inc. (SNTI) is $60.00. The current on short-term price targets is based on 1 reports.
The forecasts for Senti Biosciences, Inc. (SNTI) range from a low of $60 to a high of $60. The average price target represents a increase of $2627.27 from the last closing price of $2.20.
The current UPSIDE for Senti Biosciences, Inc. (SNTI) is 2627.27%
Only one analyst offered a short-term price target of $60.00 for Senti Biosciences, Inc. This represents an increase of 2% from the last closing price of $2.20.